Section Arrow
ZYBT.NASDAQ
- Zhengye Biotechnology Holding Limited
Quotes are at least 15-min delayed:2026/05/19 02:37 EDT
Regular Hours
Last
 0.923
-0.0293 (-3.08%)
Day High 
0.9465 
Prev. Close
0.9523 
1-M High
1.3 
Volume 
1.48K 
Bid
0.9232
Ask
0.9558
Day Low
0.923 
Open
0.9465 
1-M Low
0.78 
Market Cap 
45.13M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.96 
20-SMA 0.94 
50-SMA 0.92 
52-W High 13.08 
52-W Low 0.68 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.47/--
Enterprise Value
54.31M
Balance Sheet
Book Value Per Share
0.78
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
116.36M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SBFMSunshine Biopharma Inc0.51+0.2259+79.51%-- 
HIMSHims & Hers Health22.29-2.76-11.02%-- 
ESPREsperion Therapeutics3.13+0.01+0.32%-- 
CGCCanopy Growth Corp0.9823-0.0577-5.55%-- 
VTRSViatris16.5+0.02+0.12%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.